1. Home
  2. IRIX vs LGVN Comparison

IRIX vs LGVN Comparison

Compare IRIX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • LGVN
  • Stock Information
  • Founded
  • IRIX 1989
  • LGVN 2014
  • Country
  • IRIX United States
  • LGVN United States
  • Employees
  • IRIX N/A
  • LGVN N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LGVN Medicinal Chemicals and Botanical Products
  • Sector
  • IRIX Health Care
  • LGVN Health Care
  • Exchange
  • IRIX Nasdaq
  • LGVN Nasdaq
  • Market Cap
  • IRIX 20.2M
  • LGVN 17.6M
  • IPO Year
  • IRIX 1996
  • LGVN 2021
  • Fundamental
  • Price
  • IRIX $1.04
  • LGVN $0.75
  • Analyst Decision
  • IRIX
  • LGVN Strong Buy
  • Analyst Count
  • IRIX 0
  • LGVN 2
  • Target Price
  • IRIX N/A
  • LGVN $6.50
  • AVG Volume (30 Days)
  • IRIX 36.0K
  • LGVN 397.7K
  • Earning Date
  • IRIX 11-11-2025
  • LGVN 11-04-2025
  • Dividend Yield
  • IRIX N/A
  • LGVN N/A
  • EPS Growth
  • IRIX N/A
  • LGVN N/A
  • EPS
  • IRIX N/A
  • LGVN N/A
  • Revenue
  • IRIX $49,744,000.00
  • LGVN $1,437,000.00
  • Revenue This Year
  • IRIX $9.61
  • LGVN N/A
  • Revenue Next Year
  • IRIX N/A
  • LGVN N/A
  • P/E Ratio
  • IRIX N/A
  • LGVN N/A
  • Revenue Growth
  • IRIX 0.09
  • LGVN N/A
  • 52 Week Low
  • IRIX $0.78
  • LGVN $0.63
  • 52 Week High
  • IRIX $1.95
  • LGVN $2.31
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 42.91
  • LGVN 38.61
  • Support Level
  • IRIX $1.00
  • LGVN $0.76
  • Resistance Level
  • IRIX $1.10
  • LGVN $0.85
  • Average True Range (ATR)
  • IRIX 0.04
  • LGVN 0.04
  • MACD
  • IRIX 0.01
  • LGVN -0.01
  • Stochastic Oscillator
  • IRIX 38.49
  • LGVN 5.62

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Share on Social Networks: